ClinConnect ClinConnect Logo
Search / Trial NCT06076551

Sex Difference of Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease

Launched by KOREA UNIVERSITY ANAM HOSPITAL · Oct 6, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how men and women experience problems with small blood vessels in the heart, specifically in patients who have non-obstructive coronary artery disease. This condition can cause chest pain or other symptoms, even when the main arteries are not blocked. The researchers want to understand if there are differences between sexes in how these small blood vessels work, which could help improve treatment for patients with microvascular angina, a type of chest pain linked to these issues.

To be eligible for the trial, participants should be experiencing chest pain or similar symptoms, but their coronary arteries should not be significantly narrowed (less than 50% blockage). The trial is open to all genders and is currently recruiting patients aged 18 to 75. Participants can expect to have tests done to evaluate the function of their heart's small blood vessels. It's important to note that certain health conditions, like moderate heart valve disease or severe kidney problems, may exclude someone from joining the study. This research aims to find better ways to diagnose and treat heart issues, especially in women, who may experience different symptoms than men.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Typical/atypical chest pain or ischemic symptoms including dyspnea
  • No significant coronary artery stenosis (\<50% stenosis) in coronary angiography or computed tomography
  • Exclusion Criteria:
  • ≥ Moderate valvular heart disease
  • Congenital heart disease
  • Chronic renal failure (estimated glomerular filtration rate \<30 ml/min/1.73m2) or end-stage renal failure undergoing hemodialysis or peritoneal dialysis
  • Asthma, chronic obstructive pulmonary disease and primary pulmonary hypertension
  • Receiving anticancer drugs
  • Vasculitis associated with autoimmune diseases
  • Atrioventricular block with more than second degrees, symptomatic bradycardia, cryo-node failure syndrome, Wolff-Parkinson-White (WPW) patients

About Korea University Anam Hospital

Korea University Anam Hospital is a leading academic medical institution in South Korea renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies that aim to improve patient outcomes and contribute to medical knowledge. With a strong emphasis on ethical practices and patient safety, Korea University Anam Hospital collaborates with various stakeholders to facilitate cutting-edge research across diverse therapeutic areas, fostering an environment that promotes scientific discovery and translational medicine.

Locations

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Seong-Mi Park, PhD

Principal Investigator

Korea University Anam Hospital

Mi-Na Kim, PhD

Study Chair

Korea University Anam Hospital

Dong-Hyuk Cho, PhD

Study Chair

Korea University Anam Hospital

So Ree Kim, PhD

Study Chair

Korea University Anam Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported